Venture Capital

XPPen's new Artist Pro 27 (Gen 2) packs a 4K 120Hz screen, elite color accuracy, and a full suite of accessories to challenge the professional market.

A 30-year-old breakthrough could revolutionize physics and cancer detection. Its inventor now demands a public test to prove it, alleging a cover-up.

Samyang Corp. debuts Kestose, a high-purity crystalline fiber that tackles sugar reduction and gut health, aiming to disrupt the functional ingredients market.

Tescan's new Seoul demo lab is a strategic move to support South Korea's dominance in AI memory and advanced packaging amid a global chip war.

Thomas J. Kent Jr.'s investment firm expands to the tech hub, signaling a strategic play beyond traditional VC and a long-term bet on global innovation.

As AI agents write more code, security risks soar. Keycard's new platform offers runtime governance to safely unleash AI's full productivity potential.

Global EV leader Zenobē acquires California's Revolv, pushing into the North American truck market despite recent volatility and signaling long-term confidence.

With a new 38,000 sq ft Torrance facility, SpaceX veterans at Vital Lyfe aim to mass-produce a revolutionary portable desalination device this summer.

Link management giant Bitly appoints Matt Young as CTO, signaling a strategic push under CEO Peter Krivkovich to leverage AI for innovation and security.

A new AI tool promises to help doctors solve complex cases where lab tests are normal, using 'causal reasoning' to find the root cause of illness.

A nonprofit aims to channel $1B annually into freshwater projects, but with a catch: every dollar must be data-driven and its impact verified.

With AI's energy demand soaring, Claros has secured $30M to advance its 'chip-to-grid' platform, promising a new era of data center efficiency.

Lingerie Fighting Championships is betting on a new TV deal to turn its 5 million social followers into a mainstream empire. But can it conquer the living room?

Curia announces major upgrades to its UK sterile manufacturing and US biologics platforms, a strategic move to accelerate drug development timelines.

In a landmark deal, Suntex acquires 13 Florida marinas, crossing 100 locations nationwide and signaling a new era for boaters and waterfront real estate.

Ag-tech leader Carbon Robotics surpasses $100M in revenue, appoints a new CFO, and solidifies its global leadership in AI-driven sustainable farming.

Biotech firm Humacyte raises $20M to accelerate sales of its FDA-approved Symvess® and fund crucial trials for new hemodialysis applications.

Healthcare advisory giant Chartis is acquiring AI startup Leap AI, signaling a major industry shift toward building bespoke AI solutions for healthcare.

With the launch of Crimson Desert, MAINGEAR drops a hyper-exclusive PC. Only 30 exist, packing elite AMD hardware for a cool $4,499. Is it worth it?

With pivotal trials advancing, key FDA alignment, and a strong cash position, Taysha Gene Therapies charts a clear path toward a potential breakthrough.